Home › Mantle Cell Lymphoma › Connecticut › New Haven
Mantle Cell Lymphoma clinical trials in New Haven, CT
5 studies for Mantle Cell Lymphoma are looking for participants at sites in and around New Haven (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
RecruitingPhase 3
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 mi away
- Smilow Cancer Hospital-Derby Care Center, Derby · 8 mi away
- and 1 more
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
RecruitingPhase 3
- Yale University Yale Cancer Center, New Haven
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RecruitingPhase 1
- Yale University School of Medicine - Yale Cancer Center, New Haven
DALY II USA/ MB-CART2019.1 for DLBCL
RecruitingPhase 2
- Yale University, New Haven
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RecruitingPhase 1
- Yale Cancer Center, New Haven
Mantle Cell Lymphoma trials in other cities
- Baldwin Park, CA15 studies
- Houston, TX15 studies
- Durham, NC13 studies
- New York City, NY12 studies
- Milwaukee, WI12 studies
- Seattle, WA12 studies
- Boston, MA11 studies
- Columbus, OH11 studies
- Nashville, TN11 studies
- Chicago, IL10 studies
- Portland, OR9 studies
- Rochester, MN9 studies
Other studies in New Haven
- Non-Small Cell Lung Cancer41 studies
- Breast Cancer37 studies
- Cancer (all types)33 studies
- Metastatic Cancer23 studies
- Lung Cancer22 studies
- Head and Neck Squamous Cell Carcinoma22 studies
- Ovarian Cancer21 studies
- Colorectal Cancer20 studies
- Prostate Cancer20 studies
- Opioid Overdose18 studies
- Alcohol Use Disorder (AUD)17 studies
- Acute Myeloid Leukemia17 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.